Krsnaa Diagnostics' board has approved the financial results for the quarter, reporting consolidated revenue of ₹192.98 Cr and profit of ₹20.52 Cr.

This reflects strong growth compared to the previous year.

The company's board has also declared a final dividend of ₹2.75 per share for FY25. An Annual General Meeting is scheduled to approve the Director's report and consider the continued appointment of Director Mr. Chetan Desai.

Separately, the company is appealing an income tax demand of ₹51.39 Cr for various assessment years, having paid ₹10.28 Cr under protest, with management anticipating no material financial impact.